Hanne Capital
Overview
Founded in 2017, Hanne Capital is a healthcare venture capital fund focusing on growth opportunities in the Greater China. The Founding Partners are industry veterans with years of senior leadership e…
Investment Focus
- Companies in early-stage and growth-stage phases
- Focus on healthcare and biotechnology sectors
- Potential for significant market impact and innovation
Get the full list of 54,000+ investors
Hanne Capital and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Hanne Capital
What sectors does Hanne Capital invest in?
Hanne Capital invests in Healthcare, Pharmaceuticals, Medical Devices, Biotechnology, Immuno-Oncology and Oncolytic Virus, and is based in 龙华中路600号 上海, China. Hanne Capital is listed as a private equity in the ConnectSafely investor database.
What stage does Hanne Capital invest at?
Hanne Capital backs companies at Seed, Series A, Series B and Growth, writing cheques of 250K - 5M.
Which regions does Hanne Capital invest in?
Hanne Capital invests across United States, Hong Kong and China.
Who are the partners at Hanne Capital?
Team members listed for Hanne Capital include Edward Zhou (Founder & Managing Partner).
How do I contact Hanne Capital?
Hanne Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
